Events

*Dates for all events are to be confirmed because of the COVID-19 pandemic

august

10augallday8th Annual Immuno-Oncology SummitAugust 10 – 14, 2020Westin Copley Place, Boston

september

14sepallday6TH INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE (CICON) 2020September 14 – 17, 2020New York, USA

october

18oct(oct 18)9:29 am20(oct 20)9:29 amHUPO 2020 – 19th Human Proteome Organization World CongressOctober 18-20, 2020Stockholm, Sweden

november

11novalldaySITC 2020 Society for Immunotherapy of Cancer (SITC) 35th Annual ConferenceNovember 11 – 15, 2020Maryland, USA

FEATURED PRODUCTS

IMMUNOME Protein Array

High-throughput multiplexed autoantibody screening protein array containing 1600+
autoantigens

ImmuSAFE COVID Tests

Contains correctly folded antigens from SARS-CoV-2 and 25 other Corona and Influenza
viruses

SARS-CoV-2 Antigens

7 Recombinant SARS-CoV-2 antigens expressed using the patented KREX™ functional proteomics technology

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

2008 – 2020© Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361 

X